Literature DB >> 10964499

Syndecan-1 signals independently of beta1 integrins during Raji cell spreading.

C S Lebakken1, K J McQuade, A C Rapraeger.   

Abstract

Syndecan-1-expressing Raji lymphoid cells (Raji-S1 cells) bind and spread rapidly when attaching to matrix ligands that contain heparan sulfate-binding domains. However, these ligands also contain binding sites for integrins, which are widely known to signal, raising the question of whether the proteoglycan core protein participates in generation of the signal for spreading. To address this question, the spreading of the Raji-S1 cells is examined on ligands specific for either beta1 integrins, known to be present on the Raji cells, or the syndecan-1 core protein. The cells adhere and spread on invasin, a ligand that activates beta1 integrins, the IIICS fragment of fibronectin, which is a specific ligand for the alpha4beta1 integrin, or mAb281.2, an antibody specific for the syndecan-1 core protein. The signaling resulting from adhesion to the syndecan-specific antibody appears integrin independent as (i) the morphology of the cells spreading on the antibody is distinct from spreading initiated by the integrins alone; (ii) spreading on the syndecan or integrin ligands is affected differently by the kinase inhibitors tyrphostin 25, genistein, and staurosporine; and (iii) spreading on the syndecan-specific antibody is not disrupted by blocking beta1 integrin activation with mAb13, a beta1 inhibitory antibody. These data demonstrate that ligation of syndecan-1 initiates intracellular signaling and suggest that this signaling occurs when cells expressing syndecan-1 adhere to matrix ligands containing heparan sulfate-binding domains. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964499     DOI: 10.1006/excr.2000.4981

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Interaction of syndecan and alpha6beta4 integrin cytoplasmic domains: regulation of ErbB2-mediated integrin activation.

Authors:  Haiyao Wang; LuAnn Leavitt; Ravishankar Ramaswamy; Alan C Rapraeger
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

Review 2.  Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.

Authors:  Patricia J Keely
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-07       Impact factor: 2.673

Review 3.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

4.  MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.

Authors:  Peter Chen; Laura E Abacherli; Samuel T Nadler; Ying Wang; Qinglang Li; William C Parks
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

Review 5.  Syndecans in tumor cell adhesion and signaling.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  Reprod Biol Endocrinol       Date:  2004-01-07       Impact factor: 5.211

6.  Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins.

Authors:  O Jung; V Trapp-Stamborski; A Purushothaman; H Jin; H Wang; R D Sanderson; A C Rapraeger
Journal:  Oncogenesis       Date:  2016-02-29       Impact factor: 7.485

7.  The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.

Authors:  DeannaLee M Beauvais; Brandon J Burbach; Alan C Rapraeger
Journal:  J Cell Biol       Date:  2004-10-11       Impact factor: 10.539

8.  HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration.

Authors:  Chiara Urbinati; Maria Milanesi; Nicola Lauro; Cinzia Bertelli; Guido David; Pasqualina D'Ursi; Marco Rusnati; Paola Chiodelli
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.